Category: Biopharmaceuticals
Biopharmaceuticals market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Manual Aseptic Sampling
The 2025-2030 World Outlook for Manual Aseptic Sampling This study covers the world outlook for manual aseptic sampling across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Single-Use Bioprocessing Systems
The 2025-2030 World Outlook for Single-Use Bioprocessing Systems This study covers the world outlook for single-use bioprocessing systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Bioreactors
The 2025-2030 World Outlook for Bioreactors This study covers the world outlook for bioreactors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the p ... Read More
-
The 2025-2030 World Outlook for Bioreactors and Fermenters
The 2025-2030 World Outlook for Bioreactors and Fermenters This study covers the world outlook for bioreactors and fermenters across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Immunology Treatments
The 2025-2030 World Outlook for Immunology Treatments This study covers the world outlook for immunology treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Orphan Biologic Drugs
The 2025-2030 World Outlook for Orphan Biologic Drugs This study covers the world outlook for orphan biologic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Erythropoietin Drugs
The 2025-2030 World Outlook for Erythropoietin Drugs This study covers the world outlook for erythropoietin drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Biosimilars and Follow-on Biologics Drugs
The 2025-2030 World Outlook for Biosimilars and Follow-on Biologics Drugs This study covers the world outlook for biosimilars and follow-on biologics drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
-
The 2025-2030 World Outlook for Biologics Safety Testing Instruments
The 2025-2030 World Outlook for Biologics Safety Testing Instruments This study covers the world outlook for biologics safety testing instruments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Biopharmaceutical Third Party Logistics (3PL)
The 2025-2030 World Outlook for Biopharmaceutical Third Party Logistics (3PL) This study covers the world outlook for biopharmaceutical third party logistics (3PL) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2025-2030 World Outlook for Systemic Psoriasis Biologics
The 2025-2030 World Outlook for Systemic Psoriasis Biologics This study covers the world outlook for systemic psoriasis biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Generic Biosimilar Large Molecule Injectables
The 2025-2030 World Outlook for Generic Biosimilar Large Molecule Injectables This study covers the world outlook for generic biosimilar large molecule injectables across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2025-2030 World Outlook for Biopharmaceutical Bioseparation Systems
The 2025-2030 World Outlook for Biopharmaceutical Bioseparation Systems This study covers the world outlook for biopharmaceutical bioseparation systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Single Use Bioreactors
The 2025-2030 World Outlook for Single Use Bioreactors This study covers the world outlook for single use bioreactors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Next-Generation Biologics
The 2025-2030 World Outlook for Next-Generation Biologics This study covers the world outlook for next-generation biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Biobetters - High Efficiency and Economical Costs Foster Adoption
The 2025-2030 World Outlook for Biobetters - High Efficiency and Economical Costs Foster Adoption This study covers the world outlook for biobetters - high efficiency and economical costs Foster adoption across more than 190 countries. For each year reported, estimates are given for the latent deman ... Read More
-
The 2025-2030 World Outlook for Erythropoietins
The 2025-2030 World Outlook for Erythropoietins This study covers the world outlook for erythropoietins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Erythropoietin Stimulating Agents
The 2025-2030 World Outlook for Erythropoietin Stimulating Agents This study covers the world outlook for erythropoietin stimulating agents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Cancer Biologics
The 2025-2030 World Outlook for Cancer Biologics This study covers the world outlook for cancer biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Biopharmaceutical Cold Chain Logistics
The 2025-2030 World Outlook for Biopharmaceutical Cold Chain Logistics This study covers the world outlook for biopharmaceutical cold chain logistics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Biopharmaceutical Excipients
The 2025-2030 World Outlook for Biopharmaceutical Excipients This study covers the world outlook for biopharmaceutical excipients across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Biopharmaceuticals Manufacturing Consumables Testing
The 2025-2030 World Outlook for Biopharmaceuticals Manufacturing Consumables Testing This study covers the world outlook for biopharmaceuticals manufacturing consumables testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry e ... Read More
-
The 2025-2030 World Outlook for Biosimilars and Follow-on Biologics
The 2025-2030 World Outlook for Biosimilars and Follow-on Biologics This study covers the world outlook for biosimilars and follow-on biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Biosimilar Monoclonal Antibodies
The 2025-2030 World Outlook for Biosimilar Monoclonal Antibodies This study covers the world outlook for biosimilar monoclonal antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for PEGylated Proteins
The 2025-2030 World Outlook for PEGylated Proteins This study covers the world outlook for PEGylated proteins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
Research Assistance
